1. Home
  2. IMUX vs SHMD Comparison

IMUX vs SHMD Comparison

Compare IMUX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • SHMD
  • Stock Information
  • Founded
  • IMUX 2016
  • SHMD 1864
  • Country
  • IMUX United States
  • SHMD Germany
  • Employees
  • IMUX N/A
  • SHMD N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • SHMD
  • Sector
  • IMUX Health Care
  • SHMD
  • Exchange
  • IMUX Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • IMUX 86.3M
  • SHMD 86.1M
  • IPO Year
  • IMUX N/A
  • SHMD N/A
  • Fundamental
  • Price
  • IMUX $1.00
  • SHMD $3.05
  • Analyst Decision
  • IMUX Strong Buy
  • SHMD
  • Analyst Count
  • IMUX 6
  • SHMD 0
  • Target Price
  • IMUX $12.67
  • SHMD N/A
  • AVG Volume (30 Days)
  • IMUX 923.9K
  • SHMD 64.6K
  • Earning Date
  • IMUX 02-24-2025
  • SHMD 02-25-2025
  • Dividend Yield
  • IMUX N/A
  • SHMD N/A
  • EPS Growth
  • IMUX N/A
  • SHMD 1309.32
  • EPS
  • IMUX N/A
  • SHMD 1.07
  • Revenue
  • IMUX N/A
  • SHMD $99,752,404.00
  • Revenue This Year
  • IMUX N/A
  • SHMD N/A
  • Revenue Next Year
  • IMUX N/A
  • SHMD N/A
  • P/E Ratio
  • IMUX N/A
  • SHMD $2.84
  • Revenue Growth
  • IMUX N/A
  • SHMD N/A
  • 52 Week Low
  • IMUX $0.92
  • SHMD $1.86
  • 52 Week High
  • IMUX $2.11
  • SHMD $6.13
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 50.39
  • SHMD N/A
  • Support Level
  • IMUX $0.92
  • SHMD N/A
  • Resistance Level
  • IMUX $0.97
  • SHMD N/A
  • Average True Range (ATR)
  • IMUX 0.06
  • SHMD 0.00
  • MACD
  • IMUX 0.01
  • SHMD 0.00
  • Stochastic Oscillator
  • IMUX 66.61
  • SHMD 0.00

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: